InDevR has a strong history of non-dilutive funding raises, including a $14.7M BARDA contract and recent investment from the Bill & Melinda Gates Foundation.
Organizations Involved
Bill & Melinda Gates Foundation
Founders
Dr. Kathy Rowlen
Company Description
InDevR is a biotechnology company poised to significantly impact vaccine process optimization and manufacturing with powerful new protein characterization tools. The company has launched several successful life science tool-based product lines including VaxArray and Cypher One.